The majority of US consumers decide to use OTC pain relievers based on factors other than safety, according to a survey sponsored by McNeil Consumer Healthcare, manufacturer of the brand synonymous with nonprescription pain relief, Tylenol.
The Johnson & Johnsonbusiness publishes the survey results to bring the issue to consumers' attention while it faces class action complaints alleging that Tylenol causes harm when used as directed and as FDA continues evaluating whether lower doses and more
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?